News Gilead's next gen HIV prevention trial to begin in UK UK hospital seeking ethical clearance for trial of Gilead's new PReP drug.
News NICE review sparks new call for HIV prophylaxis NICE review backs case for Truvada pre-exposure prophylaxis, say campaigners.
News Charity raises funds for legal fight over HIV drug National AIDS Trust continues legal battle over Truvada.
Views & Analysis Pre-exposure treatment to help prevent HIV Wider use of Pre-Exposure Prophylaxis (PrEP), where people who don't have HIV take a pill every day, could prevent around 7,400 new HIV infections in the UK by 2020.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
